HeyJaredCarla Cantor
- Indexed articles, last 90 days
- 2
- Latest publication
- Sep 11, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Aug 31, 2026
Latest articles
Could Tavapadon Change Parkinson's Care? (opens the original)
Read excerpt
Parkinson's disease (PD) treatment could be on the cusp of its first new dopamine agonist strategy in decades, as the FDA nears a decision on the investigational drug tavapadon later this month. If approved, the once-daily oral medication will be the first to selectively and partially activate D1/D5 dopamine receptors, establishing a novel pathway for motor symptom management. Across three pivotal phase 3 trials, tavapadon demonstrated clinical benefit both as an early-stage monotherapy and as a
Borderline Personality: Evidence Has Evolved. Care Hasnât (opens the original)
Read excerpt
Through adolescence and early adulthood, Lindsay Dow cycled through intensive psychotherapy, repeated hospitalizations, and medications that doctors kept adding or changing — none of it holding. Diagnosed with bipolar disorder at 13, she spent years in care that never seemed to address the emotional volatility and instability that were upending her life. “I would go home, take the meds, and basically lie down in my bed and wait for my life to get better,” she recalled. Nearly a decade later, Dow
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.